MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • MassDevice Today
    • Cardiovascular
    • Clinical Trials
    • Legal News
    • Orthopedics
    • Regulatory/Compliance
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • More MedTech
    • Cosmetic/Aesthetic
    • Diabetes
    • Dialysis
    • Distribution
    • Imaging
    • Otolaryngology Ear, Nose & Throat
    • Pharma
    • Respiratory
    • Wound Care
  • Blog
  • DeviceTalks Podcasts
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • Videos
    • White Papers
  • DeviceTalks
Home » FDA authorizes Quest Diagnostics/3M “real-time” Swine Flu molecular test combo

FDA authorizes Quest Diagnostics/3M “real-time” Swine Flu molecular test combo

October 16, 2009 By MassDevice staff Leave a Comment

Share

The U.S. Food and Drug Administration granted emergency use authorization for the use of Quest Diagnostics’ Simplexa 24-hour Swine Flu test on equipment made by 3M, in a move aimed at boosting lab capacity for the test during flu season.

The molecular test, which uses “real-time” polymerase chain reaction technology to identify the RNA of the A/H1N1 influenza strain, is made by Cypress, Calif.-based Quest unit Focus Diagnostics. In July, the test was the first commercial diagnostics to gain FDA emergency authorization for use on equipment made by Roche and Applied Biosystems, according to a Quest press release.

Quest’s alliance with the Minneapolis conglomerate is aimed at boosting capacity at CLIA high-complexity labs in hospitals and regional facilities. The Simplexa test identifies the presence of H1N1 RNA from nasal or throat samples; results using the 3M cycler are available in 30 to 75 minutes, although transmitting the samples and returning results usually takes about 24 hours, Focus GM John Hurrell said in the statement. The test distinguishes between the H1N1 strain and seasonal flu strains.

The emergency use authorization does not mean the test has the FDA’s blessing. It’s not FDA-cleared or approved, according to a press release. The authorization was made to help labs cope with a surge in testing demand during flu season and is good only for the duration of the Swine Flu emergency.

The companies also inked a global distribution deal that will see Focus turn the Simplexa brand into its first line of molecular diagnostic test kits, designed for the 3M equipment. Quest said more Simplexa test kits, for other diagnoses, are in the works for 2010.

Filed Under: Business/Financial News, Diagnostics, Genomics Molecular Diagnostics Tagged With: Swine Flu

In case you missed it

  • Biotronik wins FDA nod for Orsiro DES
  • Nevro shares down on Q4, 2018 miss
  • Axonics wins expanded MRI-safe CE Mark approval for r-SNM system
  • Stimwave calls Nevro patent suit ‘baseless, unfounded’
  • FDA releases brain-computer interface draft guidance
  • Ocular Therapeutix inks $38m debt financing deal
  • Sen. Warner enlists healthcare industry help on cybersecurity
  • Medtech outsourcer innovations you need to know
  • Second Sight Medical closes $35m rights offering
  • Swiss heart valve dev Novostia raises $7m
  • Dexcom beats The Street with Q4, FY18 results
  • ViewRay wins FDA nod for MRIdian system soft tissue visualization capabilities
  • Boston Scientific prices $4.3B senior notes offering
  • Abbott touts real-world data for FreeStyle Libre glucose monitor
  • Mylan launches generic sublingual film for opioid dependence
  • Propeller Health study suggests 84% of asthma inhaler use performed incorrectly
  • LivaNova wins Japanese reimbursement for Perceval aortic valve

RSS From Medical Design & Outsourcing

  • High Precision Metrology Applications
    Cellular therapies and bio-fabrications are on the verge of revolutionizing how patients are treated for some of the most serious illnesses. These regenerative approaches are giving hope to both patients and their doctors for cures where today only symptomatic treatments are available. Precision automation in the laboratory is playing a key role in allowing these… […]
  • GW Plastics expands Ireland operations
    GW Plastics (Bethel, Vt.) recently announced that it is expanding its operations at its advanced manufacturing facility in Sligo, Ireland. The company plans to invest €6 million to grow its product development, precision tooling, thermoplastic and silicone injection molding and contract assembly capabilities. It also plans to expand molding operations to a scalable 28,000 sq.… […]
  • Medtech outsourcer innovations you need to know
    The medical device industry is seeing all kinds of innovations, but people often overlook the myriad medtech outsourcer technologies making innovation possible. From tiny sensors, magnets and cameras to materials and adhesives that get the job done, contract manufacturers and other suppliers are supporting the medical device industry in myriad ways. They’re enabling everything from… […]
  • Sen. Warner enlists healthcare industry help on cybersecurity
    U.S. Senator Mark Warner (D-Va.) wants healthcare organizations’ help to improve cybersecurity. Warner — a member of the Senate Finance Committee and chair of the Senate cybersecurity caucus — sent a letter to a number of healthcare organizations yesterday, pointing to the apparent gaps in oversight and expressing concern about the impact of cyberattacks on… […]
  • How adhesives are key to unlocking wearable medical device innovation
    It turns out that adhesives are a critical component to the success of wearables. Adhesives provide solutions to design challenges and help protect users’ skin from harm. Tony Kaufman and Del R. Lawson, 3M The healthcare landscape is constantly changing, with providers continuing to focus on delivering patient-centric care. Patients are increasingly able to access… […]
  • Medbio acquires AIM Plastics
    Medbio (Grand Rapids, Mich.) announced that it has acquired Detroit-based component manufacturer AIM Plastics. The financial details of the deal were not disclosed. AIM Plastics specializes in prototype-to-production molds and complex injection molding. It offers full-service injection molding and in-house tooling capabilities for therapeutic applications in the healthcare industry. “AIM is a truly transformative add-on… […]
  • How to design home healthcare devices that people will use
    Meeting consumer demands for home healthcare technology requires a keen knowledge of user behavior. Here are four ways companies are approaching the market. Scott Thielman, Product Creation Studio The global smart home healthcare market is exploding as more medical devices are designed for use wherever the patient is, including at home. A report by Research and… […]
  • Axonics Modulation touts results of sacral neuromodulation study
    Axonics Modulation Technologies (NSDQ:AXNX) announced positive top-line results from a pivotal study of its novel implantable sacral neuromodulation (SNM) devices for the treatment of urinary and bowel dysfunction. The clinical study demonstrated that patients implanted with the Axonics r-SNM system experienced clinically meaningful and statistically significant improvements in urinary urgency incontinence (UUI) symptoms and quality of… […]
  • Okay Industries appoints new marketing manager
    Okay Industries (New Britain, Conn.) announced that it has appointed Angela Dillon as its new marketing manager. As marketing manager, Dillon willed strategic initiative that will promote the Okay brand, support business development and manage both internal and external communications for talent recruitment and retention. “I am excited to announce this new role for Angela,”… […]
  • SIG Medical wins FDA clearance for rib fracture device
    SIG Medical (Hershey, Penn.) has received FDA 510(k) clearance for its enhanced AdvantageRib System, the K183317. The system is the third rib fracture system from SIG Medical that has received 510(k) clearance recently and is being commercialized. The most recent 510(k) includes new implants that treat patients, as well as the entire spectrum of bone… […]
  • Starr Surgical signs strategic cooperation agreement with Smile Eyes
    Starr Surgical (Monrovia, Calif.) recently announced that it has signed a strategic cooperation agreement with the Smile Eyes group in Germany and Austria. The Smile Eyes group is an alliance of more than 80 eye experts in 13 vision correction eye centers in Germany and Austria. Through the agreement, EVO Visian ICL lenses will be… […]

Leave a Reply Cancel reply

You must be logged in to post a comment.

Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us
Privacy
Add us on FacebookMassDevice Network
Follow us on Twitter@MassDevice
Connect with us on LinkedInLinkedIn
Follow us on YouTube YouTube

Copyright © 2019 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS